HA380 hemoperfutor used during cardiopulmonary bypass in patients with primary hypercholesterolemic coronary heart disease:a case report
Abstract：1. Materials and Methods
1.1 Case Report This study has been approved by the Ethics Committee of Clinical Research of Xiangya Second Hospital, Central South University [(2021) Ethical Review [Clinical Research] No. (090)]. The patient is a 23-year-old unmarried woman who was admitted to our hospital on September 3, 2023, due to skin xanthomas discovered more than 10 years ago and chest pain after activity for half a year.
Keywords：HemoperfusionHypercholesterolemiaCoronary heart diseaseCardiopulmonary bypass
Publication Date：2025-04-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 145-147 )